...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Recent Funding - Zenith CC
3
Oct 21, 2022 02:04PM
1
Oct 22, 2022 06:04PM
1
Oct 23, 2022 10:02AM
1
Oct 24, 2022 07:38AM

i agree NB - with all the Pharmas involved my belief is at least two min will make a move at some point between now & this coming spring. 

Hard to imagine all these pharmas in bed with zen now & somehow believe they will all be playing nice for several more years working on this without one of them willing to pull the trigger. The drug has been working great so far & the safety record has been incredible. 

If nothing else one of them will scoop it up & leave it on the back burner to maybe protect their existing drug sales they have in the market now. Guess my biggest disagreement with the posts put up is the timeline's guessed.

 Can't even begin to believe that this SALE is years away with all the competition sitting  there right now, not a chance.

 Even if I really wanted zen to work with all the existing Pharmas for several more years in a chance of an even bigger pay out I just don't see it happening.  

in regards to Toni,not sure but y wouldnt Hepa of recieved shares in the spin off too?

Share
New Message
Please login to post a reply